Literature DB >> 1600707

The distribution and severity of diabetic foot disease: a community study with comparison to a non-diabetic group.

D P Walters1, W Gatling, M A Mullee, R D Hill.   

Abstract

A surveillance programme was undertaken to identify all diabetic patients with foot disease in a defined population with the same age and sex structure as that of the UK. Of 1150 diabetic patients identified, 1077 were reviewed either at home or in hospital. The presence of foot deformity, amputation, and foot ulceration was determined. The site, depth, and duration of ulcers were recorded and any previous ulceration noted. All feet with ulcers were X-rayed. A non-diabetic comparison group of 480 age- and sex-matched individuals were also examined by the same observer. The prevalence of past or present foot ulceration was 7.4 (95% CI 5.8-9.0)% in diabetic patients and 2.5 (95% CI 1.1-3.9)% in the non-diabetic group, yielding an odds ratio of 2.94 (95% CI 1.58-5.48) (p less than 0.001) for the occurrence of foot ulceration in diabetic patients. Of the ulcers found on examination, 39.4% were neuropathic, 24.2% were vascular, and 36.4% were mixed. Multiple logistic regression analysis of selected variables revealed that duration of diabetes, absent light touch, impaired pain perception, absent dorsalis pedis pulse, and the presence of any retinopathy were significant predictors of the presence of foot ulcers. The prevalence of amputation in diabetic patients was 1.3 (95% CI 0.6-2.0)%, but there were no amputations in the non-diabetic group.

Entities:  

Mesh:

Year:  1992        PMID: 1600707     DOI: 10.1111/j.1464-5491.1992.tb01796.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  26 in total

1.  Complications of diabetes: screening for retinopathy and management of foot ulcers.

Authors:  A Melville; R Richardson; A McIntosh; C O'Keeffe; J Mason; J Peters; A Hutchinson
Journal:  Qual Health Care       Date:  2000-06

Review 2.  Cost-effective management of diabetic foot ulcers. A review.

Authors:  G Ragnarson-Tennvall; J Apelqvist
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

3.  The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration.

Authors:  Suzan Tabur; Mehmet Ali Eren; Yakup Çelik; Omer Faruk Dağ; Tevfik Sabuncu; Zeynel Abidin Sayiner; Esen Savas
Journal:  Wien Klin Wochenschr       Date:  2014-11-15       Impact factor: 1.704

4.  Prevalence and healthcare costs associated with the management of diabetic foot ulcer in patients attending Ahmadu Bello University Teaching Hospital, Nigeria.

Authors:  Umar Mukhtar Danmusa; Iorliam Terhile; Idris Abdullahi Nasir; Auwal Alkasim Ahmad; Habiba Yahaya Muhammad
Journal:  Int J Health Sci (Qassim)       Date:  2016-04

Review 5.  A risk-benefit assessment of metformin in type 2 diabetes mellitus.

Authors:  H C Howlett; C J Bailey
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

6.  Five-year follow-up of a cohort of people with their first diabetic foot ulcer: the persistent effect of depression on mortality.

Authors:  K Winkley; H Sallis; D Kariyawasam; L H Leelarathna; T Chalder; M E Edmonds; D Stahl; K Ismail
Journal:  Diabetologia       Date:  2011-11-06       Impact factor: 10.122

Review 7.  Diabetic foot ulcers. Pathophysiology, assessment, and therapy.

Authors:  C K Bowering
Journal:  Can Fam Physician       Date:  2001-05       Impact factor: 3.275

8.  The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues.

Authors:  Hariharan Thangarajah; Dachun Yao; Edward I Chang; Yubin Shi; Leila Jazayeri; Ivan N Vial; Robert D Galiano; Xue-Liang Du; Raymon Grogan; Michael G Galvez; Michael Januszyk; Michael Brownlee; Geoffrey C Gurtner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-28       Impact factor: 11.205

Review 9.  Diabetic foot wounds: the value of negative pressure wound therapy with instillation.

Authors:  Luca Dalla Paola
Journal:  Int Wound J       Date:  2013-12       Impact factor: 3.315

10.  [Epidemiology and classification of diabetic foot syndrome].

Authors:  J Teichmann; D Sabo
Journal:  Orthopade       Date:  2009-12       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.